Arbutus Biopharma - 48 Year Dividend History | ABUS
Historical dividend payout and yield for Arbutus Biopharma (ABUS) since 1971. The current TTM dividend payout for Arbutus Biopharma (ABUS) as of June 17, 2019 is $0.00. The current dividend yield for Arbutus Biopharma as of June 17, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Arbutus Biopharma Corporation is a biopharmaceutical company which is focused on discovering, developing and commercializing a portfolio of drug candidates for chronic hepatitis B infection. The Company's products include TKM-HBV, Cyclophilin Inhibitor-OCB-030, TLR9 Agonist (CYT-003), Capsid Assembly Inhibitors, Surface Antigen Secretion Inhibitors, STING Agonists, cccDNA Formation Inhibitors, cccDNA Epigenetic Modifiers, TKM-PLK1, GI-NET and ACC, HCC, TKM-Ebola, TKM-Ebola-Guinea, TKM-Marburg, TKM-HTG and TKM-ALDH which are in different clinical trial stage. Arbutus Biopharma Corp, formerly known as Tekmira Pharmaceuticals Corporation, is headquartered in Vancouver, BC.